The Minneapolis biotech that stopped trying to kill the bacteria in your mouth - and started reprogramming what they eat.
Vincent Musi would frame it simply: a woman, a microscope, and a grudge against the way medicine ignores the mouth.
Walk into the lab at 1400 Van Buren Street NE, in the arts district of Northeast Minneapolis, and you will not find the usual oral-care theater - no foaming mint, no promises of a whiter smile by Tuesday. What you find instead is a company that treats the human mouth the way an ecologist treats a wetland: as a living system that can be tipped toward health or toward ruin, depending on what you feed it. Primal Health is small, stubborn, and unusually specific about the enemy. The enemy is not bacteria. The enemy is the wrong bacteria, eating the wrong things.
The idea has a name - SMMRT Science, for Selective Microbial Metabolism Regulation Technology - and a founder who did not arrive at it through a marketing brief. Dr. Emily Stein was a Berkeley-trained microbiologist and a Stanford immunology fellow in 2009 when her grandmother had a stroke shortly after a tooth extraction. Stein believed the two were connected. So she did what few grieving grandchildren do: she collected the microbes from her grandmother's mouth and took them back to the lab.
It's putting microbes on a keto diet.
A century of oral care has been an arms race. Primal Health quit the race and rewrote the rules.
Antibiotics and antiseptics carpet-bomb. They kill the harmful microbes and the helpful ones together, then leave the field open for whoever grows back fastest - often the bad guys. Primal Health's answer is quieter and stranger. Its lozenges block harmful bacteria from metabolizing sugars and carbohydrates while nudging them toward proteins and amino acids. Starve the troublemakers of what they crave, feed the beneficial strains what they need, and the mouth's ecosystem rebalances on its own. No scorched earth. Just a shifted diet.
Four steps, no antibiotics, one rebalanced microbiome.
A fast-melt lozenge releases the SMMRT formula across the oral microbiome.➞
Harmful bacteria lose their ability to feed on sugars and carbs.➞
Beneficial microbes are activated to metabolize proteins and thrive.➞
Less acid, less inflammation, fresher breath, healthier gums.
People and pets share the same problem. Primal Health built the same solution for both.
Fast-melt lozenges - including pHossident and PROtektin - that shift harmful bacteria off sugars, strengthen the microbiome, and cut acid and bad odors. Available in multiple flavors.
A prebiotic dental powder you add to your dog's water. No brushing, no wrestling - just SMMRT Science feeding the beneficial bacteria that keep a dog's mouth healthy.
An SMMRT lozenge formulated to help strengthen enamel by regulating how bacteria metabolize in the mouth.
An SMMRT lozenge designed to accelerate the growth of beneficial microbes for healthier gums and reduced bleeding.
Half research engine, half consumer brand - and the sales mix shows it.
Figures per press reporting; treat as approximate.
Anthropology at Iowa, then microbiology and immunology, then a Ph.D. at UC Berkeley, then a fellowship at Stanford School of Medicine. Eighteen issued patents. Five startups. And through all of it, one fixation: that the tiny organisms we ignore are quietly steering our health. Stein founded Primal Therapies in the Bay Area in 2012 and, five years later, moved to Minneapolis to launch Primal Health with co-founder Lindsey Campbell. Her second muse was a rescue dog named Tinzley, who nearly died of a gum infection - and who inspired the pet line.
I want to build solutions that protect against unforeseen consequences of microbe-driven diseases.
From a hospital room to a shelf in the dental aisle.
Stein's grandmother has a stroke after a tooth extraction. Stein begins investigating the oral-systemic link.
Founded in the Bay Area; SMMRT Science research begins in earnest.
Stein relocates to Minneapolis and co-founds the oral-health subsidiary with Lindsey Campbell.
The prebiotic pet dental line launches, extending SMMRT Science from people to pets.
An NIH-funded study reports reduced bleeding gums and bad-breath bacteria over six weeks of SMMRT lozenges.
Primal Health's ambition doesn't end at the gum line. The company frames oral dysbiosis as an entry point - a first domino - to conditions the medical world usually treats far downstream: cardiovascular disease, diabetes, metabolic disorders, even Alzheimer's and Parkinson's. Prevention over prescription. Ecosystem over eradication. It is a small Minneapolis bet on a very large idea: that if you fix the microbiome where it starts, you may never have to fight it where it ends.
SMMRT modulates metabolism instead of killing broadly - sidestepping the antimicrobial-resistance trap.
A funded clinical study backs the human formula's effect on gum health and breath.
One core technology, translated across two species that share the same oral biology.